Insider sale
VIR BIOTECHNOLOGY, INC.
$9.53M
1.67M shares
What this filing means
SVF ENDURANCE (CAYMAN) LTD plans to sell 1.67M shares of VIR BIOTECHNOLOGY, INC. valued at approximately $9.53M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/3/2025ACC: 0001493152-25-016892
10% Owner
Since Oct 2019
1.67M
Shares to sell
$9.53M
Approx. market value
21.67M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Acquired upon the automatic conversion of convertible preferred stock. The convertible preferred stock was acquired and fully paid for in multiple transactions from August 2017 to January 2019.
Cash
10/16/2019
21.67MTotal acquired21.67M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/16/2019 | Acquired upon the automatic conversion of convertible preferred stock. The convertible preferred stock was acquired and fully paid for in multiple transactions from August 2017 to January 2019. Cash | 21.67M | — |
| Total | 21.67M | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.67M
Market value
$9.53M
10/3/2025
Total
Units
1.67M
Value
$9.53M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/3/2025 | 1.67M | $9.53M | NASDAQ | Planned |
| Total | 1.67M | $9.53M | ||